Provided By GlobeNewswire
Last update: May 1, 2025
- Implementation of cost reduction initiatives to position Pliant for execution of late-stage clinical trials
- Pliant will reduce its current workforce by approximately 45%
PLIANT THERAPEUTICS INC
NASDAQ:PLRX (7/24/2025, 8:00:00 PM)
1.59
+0.01 (+0.63%)
Find more stocks in the Stock Screener